Alliance Bioenergy Plus (ALLM) Stock Price, News & Analysis

Company Overview

Alliance Bioenergy Plus, Inc. is a technology company, which engages in the development and commercialization of technology solutions for renewable energy, biofuels, and bioplastics technology sectors. It offers CTS 2.0, a mechanical and chemical dry process for converting cellulose material into sugar for use in the biofuels industry. The company was founded on March 28, 2012 by Daniel de Liege, Mark W. Koch, and Johan Sturm and is headquartered in Palm Beach Gardens, FL.

Key Stats

• Today's Range: $0.26 to $0.30
• 50-Day Range: $0.28 to $0.28
• 52-Week Range: $0.05 to $1.50
• Volume: 329,500 shs
• Average Volume: 467,609 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ALLM Stock Analysis - Frequently Asked Questions

How have ALLM shares performed this year?

Alliance Bioenergy Plus' stock was trading at $0.28 at the beginning of the year. Since then, ALLM stock has increased by 0.0% and is now trading at $0.28.

How do I buy shares of Alliance Bioenergy Plus?

Shares of ALLM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Alliance Bioenergy Plus own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Bioenergy Plus investors own include Advanced Micro Devices (AMD), American Battery Technology (ABML), Best Buy (BBY), Clean Energy Technologies (CETY), Etsy (ETSY), SunHydrogen (HYSR) and Infrastructure and Energy Alternatives (IEA).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Multi-Sector Conglomerates
• Industry: Conglomerates
• Sub-Industry: Chemicals
• Current Symbol: OTCMKTS:ALLM
• CIK: 1549145
• Web: www.alliancebioe.com
• Phone: (561) 359-8222
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A